Methods of treating cardiomyopathy associated with genetic disorders
US10973869B2 · kind B2 · utility
0Cited by
0References
19Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 16, 2018 |
| Grant date | Apr 13, 2021 |
| Priority date | — |
| Expiry date | May 16, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides, among other things, methods of treating a cardiac disease or condition in a patient having muscular dystrophy that can include administering to a subject suffering from, susceptible, or diagnosed with muscular dystrophy an angiotensin (1-7) peptide.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.